- Joined
- Dec 17, 2007
- Messages
- 3,391
- Reaction score
- 4,410
Interesting case.
Patient with metastatic prostate cancer (several bone mets after prostatectomy and adjuvant RT).
He started ADT over 3 years ago and got up-front 6 cycles of Docetaxel. PSA dropped to around 1.5 ng/ml, remained stable for almost 2 years and rose this winter to 2.5 ng/ml.
Whole-body MRI showed a viable lesion in the spine, the rest of the lesions seemed stable. We had done yearly wbMRI, so it was rather easy to pick up.
I SBRTed the lesion and measured the PSA immediately prior to treatment delivery. It was at 2.7 ng/ml. Two months later he came back for a follow-up, PSA was 4.5 ng/ml. We were both disappointed, since it started looking like mCRPC, we decided to check the PSA again a few weeks later and schedule a new scan.
Now, four weeks later and the PSA dropped to 2.8 ng/ml (almost the same as prior to SBRT).
We hope it will continue to drop.
Was this a PSA-bounce caused by the SBRT? I know about PSA-bounces in primary RT of the prostate but have never seen one before when treating bone mets. Testosterone measured all the time, was always very low. My nuclear medicine friends say, they have seen that with Lutetium PSMA therapy a few times.
Patient with metastatic prostate cancer (several bone mets after prostatectomy and adjuvant RT).
He started ADT over 3 years ago and got up-front 6 cycles of Docetaxel. PSA dropped to around 1.5 ng/ml, remained stable for almost 2 years and rose this winter to 2.5 ng/ml.
Whole-body MRI showed a viable lesion in the spine, the rest of the lesions seemed stable. We had done yearly wbMRI, so it was rather easy to pick up.
I SBRTed the lesion and measured the PSA immediately prior to treatment delivery. It was at 2.7 ng/ml. Two months later he came back for a follow-up, PSA was 4.5 ng/ml. We were both disappointed, since it started looking like mCRPC, we decided to check the PSA again a few weeks later and schedule a new scan.
Now, four weeks later and the PSA dropped to 2.8 ng/ml (almost the same as prior to SBRT).
We hope it will continue to drop.
Was this a PSA-bounce caused by the SBRT? I know about PSA-bounces in primary RT of the prostate but have never seen one before when treating bone mets. Testosterone measured all the time, was always very low. My nuclear medicine friends say, they have seen that with Lutetium PSMA therapy a few times.